🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Nobel prize in medicine awarded for immune system cancer research ti.me/2NX4Z6n

"There is no God. No one directs the universe," physicist Stephen Hawking says in his final book. cnn.it/2COQqff

Bottom-up synthetic biologists predict that the first fully artificial cells could spark to life in little more than a decade. go.nature.com/2Oz6C5y

Online Now: Tumor organoids: Opportunities and challenges to guide precision medicine dlvr.it/S62VKt

gd T cells are effectors of immune checkpoint blockade in MMR-deficient colon cancers with antigen presentation defects: biorxiv.org/content/10.110… Great team effort of de Miranda Lab @jorisvandehaar @VeningaVivien #colorectalcancer #gdTcells #immunotherapy #checkpointblockade

👌 After an inspiring start at the #VIBTraining on organoid modeling, we had more exciting updates today on organoids in cancer research by Henner Farin & Mohammed Mosa VomLaborInDiePraxis, Emile Voest & Vivien Veninga Antoni van Leeuwenhoek @VeningaVivien

It’s finally out! Our most recent work published today in nature: γδ T cells are effectors of immunotherapy in cancers with HLA class I defects. nature.com/articles/s4158… 🧵below 👇👇👇

Impossible immunotherapy responses? It's the gamma delta's bro! Thrilled to see our work on γδ T cells and "impossible" immunotherapy responses of B2M mutant cancers in nature. 🧵 below 👇👇👇

There it is 🥳

Very nice work by the Garnett Lab. Congrats to @mattcoelho3 and the team 🎉

Cancer Discovery #ResearchWatch: γδ #TCells Mediate Immunotherapy Response in HLA Class I–Deficient Cancers, summarizing the work of Natasja de Vries, @jorisvandehaar, Vivien Veninga, Myriam Chalabi, Noel F. de Miranda, Emile E. Voest, et al. bit.ly/3XuPEdc The Netherlands Cancer Institute LUMC Leiden

γδ T cells mediate immunotherapy responses when cancers lack MHC class I dlvr.it/ShpS8W

γδ T cells unveil invisible tumors dlvr.it/Sj2PPV #immunology

Wonderful N&V in Nature Immunology by actual #gdTcell experts Bruno Silva-Santos and S. Mensurado (thank you!), inspired by our recent work. It's amazing to see the ethusiasm from the #gdTcell community. #cancer #immunotherapy nature.com/articles/s4159…

Thank you @forum_gd Payal Yokota for the invite and the opportunity to share our recent findings and thoughts on gd T cells as effectors in HLA class I negative tumors. It was my pleasure and thanks to everyone for a great discussion!

Delivery of therapeutic molecules is a major bottleneck for treating a wide range of diseases. Today we describe a new modality for delivering proteins based on an engineered contractile injection system @nature nature.com/articles/s4158…

I am very excited to share our paper on the interactions between #gdTcells and cancer cells, out today in nature! Using #CRISPR screens, we uncovered unexpected pathways in cancer cells regulating target molecules recognized by γδ T cells. @MarsonLab 1/2 nature.com/articles/s4158…

First approval for a #CRISPR therapy in the world. UK MHRA has authorized Exagamglogene autotemcel (Casgevy) this morning. What a historic and uplifting day for patients and for the gene & cell therapy field. gov.uk/government/new…